Back to top

Press Releases

Zacks Equity Research

Zacks.com featured highlights: Lancaster Colony, Sucampo Pharmaceuticals, VMware and Alexandria Real Estate Equities

LANC SCMP VMW ARE

Trades from $3

For Immediate Release

Chicago, IL – November 22, 2016 - Stocks in this week’s article include Lancaster Colony Corporation (Nasdaq:(LANC - Free Report) -Free Report),Sucampo Pharmaceuticals, Inc. (Nasdaq:(SCMP - Free Report) -Free Report), VMware, Inc. (NYSE:(VMW - Free Report) -Free Report) and Alexandria Real Estate Equities, Inc. (NYSE:(ARE - Free Report) - Free Report).

Screen of the Week of Zacks Investment Research:

4 Stocks to Buy on Solid Earnings Acceleration

Investors are always on the lookout for stocks that are ready to make a big move. Better-than-expected earnings, more often than not, lead to an uptick in shares. Consistent earnings growth enthralls almost everyone, right from the top brass to research analysts. This is because earnings are a measure of the money a company is making.

Take a company’s revenues over a given period of time, subtract the cost of production and you will have its earnings! But, earnings acceleration works even better in boosting the stock price.

Finding Future Outperformers

If you pick stocks just on the basis of earnings growth then you are paying for something that has already been reflected in the stock price. However, steady earnings acceleration helps you select stocks that haven’t caught the attention of investors yet and are consequently on the verge of solid price appreciation. This is because earnings acceleration considers both direction and magnitude of growth rates.

Earnings acceleration is basically incrementally growing EPS of a company. In other words, if the rate of a company’s quarter-over-quarter earnings growth increases over a considerable period, it is termed as earnings acceleration.

Increasing percentage of earnings growth means that the company is fundamentally sound and has been on the right track for a considerable period of time. On the other hand, a sideways percentage of earnings growth indicates a period of consolidation or slowdown, while a decelerating percentage of earnings growth may at times drag prices down.

Screening Parameters :

Let’s find stocks for which the last two quarter-over-quarter percentage EPS growth rates are more than the growth rates of the previous periods. The projected quarter-over-quarter percentage EPS growth rates are also expected to be higher than the previous periods’ growth rates.

EPS % Projected Growth (Q1)/(Q0) greater than EPS % Growth (Q0)/(Q-1) : The projected growth rate for the current quarter (Q1) over the completed quarter (Q0) has to be greater than the growth rate from the completed quarter (Q0) over one quarter ago (Q-1).

EPS % Growth (Q0)/(Q-1) greater than EPS % Growth (Q-1)/(Q-2) : The growth rate for the completed quarter (Q0) over one quarter ago (Q-1) has to be greater than the growth rate from one quarter ago (Q-1) over two quarters ago (Q-2).

EPS % Growth (Q-1)/(Q-2) greater than EPS % Growth (Q-2)/(Q-3) : The growth rate from one quarter ago (Q-1) over two quarters ago (Q-2) has to be greater than the growth rate from two quarters ago (Q-2) over three quarters ago (Q-3).

In addition to this, we have added the following parameters:

Current Price greater than or equal to $5 : This screens out the low-priced stocks.

Average 20-day volume greater than or equal to 50,000 : High trading volume implies that the stocks have adequate liquidity.

The above criteria narrowed down the universe of around 7,811 stocks to only 30. Here are the top four stocks:

Lancaster Colony Corporation (Nasdaq:(LANC - Free Report) - Free Report) manufactures and markets specialty food products for the retail and foodservice markets. The company’s expected growth rate for the current year is 7.3%. The Zacks Consensus Estimate for its current year earnings rose 3.5% over the last 60 days.

Sucampo Pharmaceuticals, Inc. (Nasdaq:(SCMP - Free Report) - Free Report) is a biopharmaceutical company that focuses on the research and development of proprietary drugs for the treatment of gastrointestinal, ophthalmic, autoimmune, and oncology-based inflammatory disorders. The company’s expected growth rate for the current year is 23.2%. The Zacks Consensus Estimate for its current year earnings scaled 18.4% over the last 60 days.

VMware, Inc. (NYSE:(VMW - Free Report) - Free Report) provides virtualization and cloud infrastructure solutions. The company’s expected growth rate for the current year is 2.7%. The Zacks Consensus Estimate for its current year earnings increased 1.3% over the last 60 days.

Alexandria Real Estate Equities, Inc. (NYSE:(ARE - Free Report) - Free Report) is a real estate investment trust (REIT). The company’s expected growth rate for the current year is 5.2%. The Zacks Consensus Estimate for its current year earnings advanced 0.14% over the last 90 days.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here .

You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today .

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance .

Zacks Restaurant Recommendations: In addition to dining at these special places, you can feast on their stock shares. A Zacks Special Report spotlights 5 recent IPOs to watch plus 2 stocks that offer immediate promise in a booming sector. Download it free »

Sign up now for your free trial today and start picking better stocks immediately. And with the backtesting feature, you can test your ideas to see how you can improve your trading in both up markets and down markets. Don’t wait for the market to get better before you decide to do better. Start learning how to be a better trader today: https://at.zacks.com/?id=111

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

About Screen of the Week

Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use. Each week, Zacks Profit from the Pros free email newsletter shares a new screening strategy. Learn more about it here https://at.zacks.com/?id=112

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Click here for your free subscription to Profit from the Pros.

Get the full Report on LANC - FREE

Get the full Report on SCMP - FREE

Get the full Report on VMW - FREE

Get the full Report on ARE - FREE

Follow us on Twitter: https://twitter.com/zacksresearch

Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Contact: Jim Giaquinto
Company: Zacks.com
Phone: 312-265-9268
Email: pr@zacks.com

Visit: https://www.zacks.com/performance

Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer .

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.

This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.